Intrinsic Frequency and the Single Wave Biopsy: Implications for Insulin Resistance
Abstract
Insulin resistance is the hallmark of classical type II diabetes. In addition, insulin resistance plays a central role in metabolic syndrome, which astonishingly affects 1 out of 3 adults in North America. The insulin resistance state can precede the manifestation of diabetes and hypertension by years. Insulin resistance is correlated with a low-grade inflammatory condition, thought to be induced by obesity as well as other conditions. Currently, the methods to measure and monitor insulin resistance, such as the homeostatic model assessment and the euglycemic insulin clamp, can be impractical, expensive, and invasive. Abundant evidence exists that relates increased pulse pressure, pulse wave velocity (PWV), and vascular dysfunction with insulin resistance. We introduce a potential method of assessing insulin resistance that relies on a novel signal-processing algorithm, the intrinsic frequency method (IFM). The method requires a single pulse pressure wave, thus the term "wave biopsy."
Additional Information
© 2015 Diabetes Technology Society. Published online before print July 16, 2015. Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NMP was supported by an American Heart Association grant.Attached Files
Supplemental Material - Supplemental_Material.pdf
Files
Name | Size | Download all |
---|---|---|
md5:8f5efd1a2d42d686c8c9010e4b1446b1
|
173.4 kB | Preview Download |
Additional details
- PMCID
- PMC4667296
- Eprint ID
- 59040
- Resolver ID
- CaltechAUTHORS:20150728-142921567
- American Heart Association
- Created
-
2015-07-28Created from EPrint's datestamp field
- Updated
-
2023-03-14Created from EPrint's last_modified field
- Caltech groups
- GALCIT